As a leading single-source provider of clinical trial supplies and services, Bilcare GCS is committed to address the challenges in traditional drug development.
Bilcare Research has partnered with US-based MeadWestVaco Corp. to jointly acquire International Labs Inc. Together, our turnkey capabilities can enable the creation of innovative, highly efficient consumer-oriented supply chains and expansion of integrated drug packaging for the global healthcare market.
With breakthrough research and development in nanotechnology and an emphasis on creating a cost-effective solution, Bilcare has created a first-of-its-kind nonClonableID™ Authentication Technology. Bilcare Technologies is a comprehensive response to counterfeiting and an indispensable tool for building confidence in consumers.